Your browser doesn't support javascript.
loading
Report from the 5th cardiovascular outcome trial (CVOT) summit.
Schnell, Oliver; Standl, Eberhard; Cos, Xavier; Heerspink, Hiddo Jl; Itzhak, Baruch; Lalic, Nebojsa; Nauck, Michael; Ceriello, Antonio.
Afiliação
  • Schnell O; Forschergruppe Diabetese e. V., Ingolstaedter Landstraße 1, Neuherberg, 85764, Munich, Germany. oliver.schnell@lrz.uni-muenchen.de.
  • Standl E; Forschergruppe Diabetese e. V., Ingolstaedter Landstraße 1, Neuherberg, 85764, Munich, Germany.
  • Cos X; Sant Marti de Provençals Primary Care Centres, Barcelona, Spain.
  • Heerspink HJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Itzhak B; George Institute for Global Health, George Institute, Camperdown, Sydney, NSW, Australia.
  • Lalic N; Clalit Health Services and Technion Faculty of Medicine, 3 Zivoni Street, Haifa, Israel.
  • Nauck M; Faculty of Medicine, University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Dr Subotica 13, Belgrade, 11000, Serbia.
  • Ceriello A; Diabetes Division, St. Josef-Hospital (Ruhr University), Bochum, Germany.
Cardiovasc Diabetol ; 19(1): 47, 2020 04 17.
Article em En | MEDLINE | ID: mdl-32303223

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Diagnostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article